Brane 2014.
Study characteristics | ||
Methods | RCT | |
Participants | Number of women randomised: 138
Setting: Stockholm, Sweden Study conducted: women recruited June 2007 to May 2012 Inclusion criteria
Exclusion criteria
State of cervix: Bishop score at presentation ranged from 1‐8 in induction group and 2‐9 in EM group. |
|
Interventions |
Induction group (n = 71): 5 hours after medication to promote 'therapeutic rest' IOL performed, with method dependent on state of cervix: intravaginal PGE2 or transcervical catheter +/‐ AROM if cervical dilation permitted; followed by IV oxytocin (augmented every 20‐30 minutes) if no progress after AROM versus EM group (n = 67): spontaneous labour awaited as long as possible; IOL if women wanted, or if the obstetrician/midwife considered suitable |
|
Outcomes |
Mother: mode of birth; experience of birth; duration of labour; labour analgesia; oxytocin for augmentation; birth presentation; postpartum haemorrhage; sphincter tears Baby: Apgar score < 7 at 5 minutes; cord artery metabolic acidosis; birthweight; head circumference; admission to NICU |
|
Notes | Women in both groups given medication to promote 'therapeutic rest' (1 g paracetamol, 10 mg zolpidem, 10 mg morphine). During active phase of labour (cervical dilation ≥ 4 cm or ROM) women monitored according to local protocol; slow progress (arrest of dilation for 2‐3 hours) was treated with AROM or oxytocin Funding: Karolinska Institute Foundations and Funds Declaration of interests: The authors reported no conflicts of interest. |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | "The randomization was performed in blocks of 5–10 in each group." Method of sequence generation not reported |
Allocation concealment (selection bias) | Unclear risk | "A sealed envelope containing coded protocols for the respective groups… was opened by the midwife." No further detail provided |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Blinding was not feasible. |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Blinded outcome assessment was not mentioned. |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Some attrition and missing data, particularly for the women’s views questionnaire. Most of the sample were included in the analyses for the primary outcome (65/71, and 64/67 in main analysis for mode of birth). The reasons for missing data for some clinical outcomes were not reported. |
Selective reporting (reporting bias) | Unclear risk | No access to trial protocol to confidently assess selective reporting. Perinatal death not reported |
Other bias | Low risk | Appeared to be free of other bias |